Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study of Gemcitabine (GEM) Versus GEM+TS-1 for Advanced Pancreatic Cancer

NCT00514163 is registered in ClinicalTrials.gov with Japan Clinical Cancer Research Organization as lead sponsor.

NCT NCT00514163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00514163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study of Gemcitabine (GEM) Versus GEM+TS-1 for Advanced Pancreatic Cancer
Lead sponsor
Japan Clinical Cancer Research Organization
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
December 31, 2010
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer